TTrialPathMatch Me to Trials
← Back to trials
RecruitingCOPDPAD

Effect of Breather in COPD Patients With Intermittent Claudication

Eligible age

50–60 yrs

Accepts

Men

Locations

0 states

Healthy volunteers

No

See if you qualify for this study

Answer a few quick questions about your location and health. Takes about a minute.

Check my eligibility →

About this study

The aim of this study To show the effect of breather on ventilatory and vascular function in COPD patient with intermittent claudication.

Sponsor: Cairo University

You may qualify if…

  • ✓ sixty male patients with diagnosed with grade I and grade II COPD their ages ranged between 55-60years
  • ✓ All patients will be clinically and medically stable when attending the study.
  • ✓ Body mass index (BMI) is 18.5 to 24.9 kg/m2.
  • ✓ History of unilateral exertional leg pain,
  • ✓ Ambulation during a graded treadmill test limited by leg pain consistent with intermittent claudication (stage II of the fontaine classification of pad),
  • ✓ And an ankle-brachial index (ABI) of 0.90 or lower at rest or 0.73 or lower after exercise.

You may not qualify if…

  • ✕ cardiovascular insufficiency,
  • ✕ Recent myocardial infarction,
  • ✕ heart failure,
  • ✕ arrhythmia,
  • ✕ DVT,
  • ✕ Intracranial hypertension,
  • ✕ Pneumonia,
  • ✕ kidney failure,

Source: ClinicalTrials.gov · NCT06529185 · last updated 2024-12-31

Effect of Breather in COPD Patients With Intermittent Claudication · TrialPath